squamous cell carcinoma Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
New/Updated Trials
Online Trials
Age Group

Female only (2)
Any (37)

Phase 1 (5)
Phase 1/2 (5)
Phase 2 (15)
Unknown (14)

Interventional (27)
Observational (10)
INTERVENTIONAL (1)

M.D. Anderson Cancer Center (2)
Merck Sharp & Dohme Corp. (2)
Shanghai Jiao Tong University School of Medicine (2)
Aalborg University Hospital (1)
Assistance Publique - Hôpitaux de Paris (1)
Assistance Publique Hopitaux De Marseille (1)
Centre Francois Baclesse (1)
Chinese Academy of Medical Sciences (1)
Chongqing University Cancer Hospital (1)
Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)
Dana-Farber Cancer Institute (1)
Emory University (1)
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello (1)
Gustave Roussy, Cancer Campus, Grand Paris (1)
H. Lee Moffitt Cancer Center and Research Institute (1)
Icahn School of Medicine at Mount Sinai (1)
Imperial College London (1)
Johns Hopkins University (1)
Massachusetts General Hospital (1)
Nader Sadeghi (1)
Peking University Third Hospital (1)
Poitiers University Hospital (1)
Radboud University (1)
RenJi Hospital (1)
Seattle Genetics, Inc. (1)
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1)
Shenzhen Geno-Immune Medical Institute (1)
The University of Hong Kong (1)
Thomas Jefferson University (1)
Tianjin Medical University Cancer Institute and Hospital (1)
TyrNovo Ltd. (1)
University Hospital, Basel, Switzerland (1)
University of California, Davis (1)
University of Texas Southwestern Medical Center (1)
Wake Forest University Health Sciences (1)

No (36)
Yes (3)

Updated trials (1)

No (39)

Adult (18+) (39)
Pediatric (Under 18) (2)

I am/have/had

I am/have/hadsquamous cell carcinoma

I am/have/hadcarcinoma

I am/have/hadcancer

I am/have/hadcavities

I am/have/hadmeasurable disease

I am/have/hadsquamous cell carcinoma of head and neck

I am/have/hadneck cancer

I am/have/hadhead and neck cancer

I am/have/hadmetastasis

I am/have/hadoropharyngeal

I am/have/hadhuman papillomavirus

I am/have/hadhead and neck carcinoma

I am/have/hadautoimmune disease

I am/have/hadchemoradiotherapy

I am/have/hadskin cancer

I am/have/hadabsolute neutrophil count

I am/have/hadneutrophil count

I am/have/hadgilbert's syndrome

I am/have/hadct scan

I am/have/hadsquamous cell carcinoma of esophagus

added new label for I am/have/had

I am looking for

I am looking forcetuximab

I am looking forfluorouracil

I am looking forpaclitaxel

I am looking forpd-1 inhibitor

I am looking fordocetaxel

I am looking foripilimumab

I am looking forcarboplatin

I am looking forleucovorin

I am looking forerythropoietin

I am looking forpembrolizumab

I am looking forerbitux

I am looking formonoclonal antibodies

I am looking forimmune checkpoint inhibitor

I am looking foranticoagulants

I am looking fornivolumab

I am looking formk-3475

I am looking forgrowth factor

I am looking fordurvalumab

I am looking forprednisone

I am looking foroxaliplatin

added new label for I am looking for

Advanced Filters

Found 5199 clinical trials

Featured trial

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Includes pre-screening
Phase 2
For pediatric ages
For Seniors
all
Recruiting

UPENN Case Test Trial 1 In Different Account (Sanofi) (Do Not Make Any Changes)

0 views
21 Aug, 2025
1 location

Featured trial

Includes pre-screening
Recruiting in 100s
Observational Study
all
Recruiting

4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer

This study determines whether a positron emission tomography (PET)/computed tomography (CT) 4-point scoring system may predict overall survival for anal squamous cell cancer patients. A 4-point scoring system involving imaging scans may help to predict how patients with anal squamous cell cancer respond to chemoradiation therapy.

0 views
14 Mar, 2022
2 locations

Multi-country trial
Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Recruiting

Study of Intratumoral (IT) MK-1454 in Combination With Intravenous (IV) Pembrolizumab (MK-3475) Compared to IV Pembrolizumab Alone as the First Line Treatment of Metastatic or Unresectable Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) (MK-1454-002)

The purpose of this study is to assess the efficacy and safety of intratumoral (IT) MK-1454 in PLUS pembrolizumab (MK-3475) compared to pembrolizumab alone as a first line treatment of adults with metastatic or unresectable, recurrent head and neck squamous cell carcinoma (HNSCC). The primary study hypotheses are that IT …

hiv test

HIV Infection

systemic therapy

squamous cell carcinoma of head and neck

squamous cell carcinoma